Visit Dohmen
We're pleased to announce that BioSoteria is now a member of the Dohmen Family of Companies.
Read More
Latest News
- Dohmen Acquires BioSoteria, the Market Leader in Drug Safety and Education
- BioSoteria Announces Call for Speaker Abstracts for the Sixth Annual Pacific Drug Safety Summit
- BioSoteria Will Host A Generic Drugs Good Safety Practices Roundtable Forum
- Upcoming Events and Educational Opportunities for 2012
- BioSoteria CEO to Co-Instruct Safety Signal Detection Tutorial at DIA Conference in Arlington, Virginia
| BioSoteria President and CEO to Keynote at the 4th Annual China Drug Safety & Public Policy Summit |
|
Category:
News
- Posted on: Thursday, 20 October 2011 00:00 |
|
BioSoteria President and CEO, Sally Van Doren, PharmD, will be a Keynote Speaker at the 4th Annual China Drug Safety & Public Summit, October 26-27, 2011 in Shanghai, China. Emeryville, CA (PRWEB) October 20, 2011 -- BioSoteria, Inc., Drug Safety and Risk Management Specialists, announced today that its President and CEO, Sally Van Doren, PharmD, will be a Keynote Speaker at the 4th Annual China Drug Safety & Public Summit. “Drug safety and postmarketing surveillance have become important public health issues in China”, says Dr. Van Doren. “The rapid development of drug safety surveillance in China is manifested in extensive organizational structure, development of large databases, and laws and regulations supporting drug safety. My keynote presentation will address lessons learned in the US risk management programs (RMPs) as they may apply to RMPs in China in future.” The keynote presentation is entitled- “Risk Management Plans: Is there Evidence that Risk Communication Strategies Reduce Patient Risk?”, and will take place on October 27, 2011 at the Crowne Plaza Century Park Hotel in Pudong Shanghai, China. |
